Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)

Javier Villacieros-Álvarez; Carmen Espejo; Georgina Arrambide; Alessandro Dinoto; Patricia Mulero; Laura Rubio-Flores; Pablo Nieto; Carmen Alcalá; Jose E. Meca-Lallana; Jorge Millan-Pascual; Pedro Martínez-García; Raphael Bernard-Valnet; Inés González-Suárez; Aída Orviz; Raquel Téllez; Laura Navarro Cantó; Silvia Presas-Rodríguez; Sergio Martínez-Yélamos; Juan Pablo Cuello; Ana Alonso; Raquel Piñar Morales; Gary Álvarez Bravo; Lakhdar Benyahya; Sophie Trouillet-Assant; Virginie Dyon-Tafan; Caroline Froment Tilikete; Aurélie Ruet; Bertrand Bourre; Romain Deschamps; Caroline Papeix; Elisabeth Maillart; Philippe Kerschen; Xavier Ayrignac; Àlex Rovira; Cristina Auger; Bertrand Audoin; Xavier Montalban; Mar Tintore; Sara Mariotto; Alvaro Cobo-Calvo; Romain Marignier

doi:10.1212/NXI.0000000000200401

Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)

Javier Villacieros-Álvarez
, Carmen Espejo
, Georgina Arrambide
, Alessandro Dinoto
, Patricia Mulero
, Laura Rubio-Flores
, Pablo Nieto
, Carmen Alcalá
, Jose E. Meca-Lallana
, Jorge Millan-Pascual
, Pedro Martínez-García
, Raphael Bernard-Valnet
, Inés González-Suárez
, Aída Orviz
, Raquel Téllez
, Laura Navarro Cantó
, Silvia Presas-Rodríguez
, Sergio Martínez-Yélamos
, Juan Pablo Cuello
, Ana Alonso

Raquel Piñar Morales, Gary Álvarez Bravo, Lakhdar Benyahya, Sophie Trouillet-Assant, Virginie Dyon-Tafan, Caroline Froment Tilikete, Aurélie Ruet, Bertrand Bourre, Romain Deschamps, Caroline Papeix, Elisabeth Maillart, Philippe Kerschen, Xavier Ayrignac, Àlex Rovira, Cristina Auger, Bertrand Audoin, Xavier Montalban, Mar Tintore, Sara Mariotto, Alvaro Cobo-Calvo, Romain Marignier

Cleveland Clinic Abu Dhabi

Research output: Contribution to journal › Comment/debate

Abstract

In the Clinical/Scientific Note Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease by Villacieros-A lvarez et al., 1 the Study Funding should read as follows: This study has been funded by Instituto Carlos III through the projects PI20/00,800 granted to A.C.-C. and co-funded by the European Union. Additional funding is from Fondation pour laide à la recherche sur la sclerose en plaques (ARSEP) (ARSEP-1276). A. Cobo-Calvo is supported by Joan Rodes contract JR19/00,007 and Javier Villacieros-A lvarez by P-FIS grant FI21/00,282.The authors regret the omission.

Original language	English
Article number	e200401
Journal	Neurology: Neuroimmunology and NeuroInflammation
Volume	12
Issue number	3
DOIs	https://doi.org/10.1212/NXI.0000000000200401
State	Published - 9 Apr 2025

Access to Document

10.1212/NXI.0000000000200401

Fingerprint

Dive into the research topics of 'Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)'. Together they form a unique fingerprint.

Cite this

Villacieros-Álvarez, J., Espejo, C., Arrambide, G., Dinoto, A., Mulero, P., Rubio-Flores, L., Nieto, P., Alcalá, C., Meca-Lallana, J. E., Millan-Pascual, J., Martínez-García, P., Bernard-Valnet, R., González-Suárez, I., Orviz, A., Téllez, R., Navarro Cantó, L., Presas-Rodríguez, S., Martínez-Yélamos, S., Cuello, J. P., ... Marignier, R. (2025). Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362). Neurology: Neuroimmunology and NeuroInflammation, 12(3), Article e200401. https://doi.org/10.1212/NXI.0000000000200401

Villacieros-Álvarez, Javier ; Espejo, Carmen ; Arrambide, Georgina et al. / Correction : Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362). In: Neurology: Neuroimmunology and NeuroInflammation. 2025 ; Vol. 12, No. 3.

@article{f164754a8771486e8ea65da215e0f4e6,

title = "Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)",

abstract = "In the Clinical/Scientific Note Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease by Villacieros-A lvarez et al., 1 the Study Funding should read as follows: This study has been funded by Instituto Carlos III through the projects PI20/00,800 granted to A.C.-C. and co-funded by the European Union. Additional funding is from Fondation pour laide {\`a} la recherche sur la sclerose en plaques (ARSEP) (ARSEP-1276). A. Cobo-Calvo is supported by Joan Rodes contract JR19/00,007 and Javier Villacieros-A lvarez by P-FIS grant FI21/00,282.The authors regret the omission.",

author = "Javier Villacieros-{\'A}lvarez and Carmen Espejo and Georgina Arrambide and Alessandro Dinoto and Patricia Mulero and Laura Rubio-Flores and Pablo Nieto and Carmen Alcal{\'a} and Meca-Lallana, \{Jose E.\} and Jorge Millan-Pascual and Pedro Mart{\'i}nez-Garc{\'i}a and Raphael Bernard-Valnet and In{\'e}s Gonz{\'a}lez-Su{\'a}rez and A{\'i}da Orviz and Raquel T{\'e}llez and \{Navarro Cant{\'o}\}, Laura and Silvia Presas-Rodr{\'i}guez and Sergio Mart{\'i}nez-Y{\'e}lamos and Cuello, \{Juan Pablo\} and Ana Alonso and Morales, \{Raquel Pi{\~n}ar\} and Bravo, \{Gary {\'A}lvarez\} and Lakhdar Benyahya and Sophie Trouillet-Assant and Virginie Dyon-Tafan and \{Froment Tilikete\}, Caroline and Aur{\'e}lie Ruet and Bertrand Bourre and Romain Deschamps and Caroline Papeix and Elisabeth Maillart and Philippe Kerschen and Xavier Ayrignac and {\`A}lex Rovira and Cristina Auger and Bertrand Audoin and Xavier Montalban and Mar Tintore and Sara Mariotto and Alvaro Cobo-Calvo and Romain Marignier",

year = "2025",

month = apr,

day = "9",

doi = "10.1212/NXI.0000000000200401",

language = "English",

volume = "12",

journal = "Neurology: Neuroimmunology and NeuroInflammation",

issn = "2332-7812",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Villacieros-Álvarez, J, Espejo, C, Arrambide, G, Dinoto, A, Mulero, P, Rubio-Flores, L, Nieto, P, Alcalá, C, Meca-Lallana, JE, Millan-Pascual, J, Martínez-García, P, Bernard-Valnet, R, González-Suárez, I, Orviz, A, Téllez, R, Navarro Cantó, L, Presas-Rodríguez, S, Martínez-Yélamos, S, Cuello, JP, Alonso, A, Morales, RP, Bravo, GÁ, Benyahya, L, Trouillet-Assant, S, Dyon-Tafan, V, Froment Tilikete, C, Ruet, A, Bourre, B, Deschamps, R, Papeix, C, Maillart, E, Kerschen, P, Ayrignac, X, Rovira, À, Auger, C, Audoin, B, Montalban, X, Tintore, M, Mariotto, S, Cobo-Calvo, A & Marignier, R 2025, 'Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)', Neurology: Neuroimmunology and NeuroInflammation, vol. 12, no. 3, e200401. https://doi.org/10.1212/NXI.0000000000200401

Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362). / Villacieros-Álvarez, Javier; Espejo, Carmen; Arrambide, Georgina et al.
In: Neurology: Neuroimmunology and NeuroInflammation, Vol. 12, No. 3, e200401, 09.04.2025.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction

T2 - Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)

AU - Villacieros-Álvarez, Javier

AU - Espejo, Carmen

AU - Arrambide, Georgina

AU - Dinoto, Alessandro

AU - Mulero, Patricia

AU - Rubio-Flores, Laura

AU - Nieto, Pablo

AU - Alcalá, Carmen

AU - Meca-Lallana, Jose E.

AU - Millan-Pascual, Jorge

AU - Martínez-García, Pedro

AU - Bernard-Valnet, Raphael

AU - González-Suárez, Inés

AU - Orviz, Aída

AU - Téllez, Raquel

AU - Navarro Cantó, Laura

AU - Presas-Rodríguez, Silvia

AU - Martínez-Yélamos, Sergio

AU - Cuello, Juan Pablo

AU - Alonso, Ana

AU - Morales, Raquel Piñar

AU - Bravo, Gary Álvarez

AU - Benyahya, Lakhdar

AU - Trouillet-Assant, Sophie

AU - Dyon-Tafan, Virginie

AU - Froment Tilikete, Caroline

AU - Ruet, Aurélie

AU - Bourre, Bertrand

AU - Deschamps, Romain

AU - Papeix, Caroline

AU - Maillart, Elisabeth

AU - Kerschen, Philippe

AU - Ayrignac, Xavier

AU - Rovira, Àlex

AU - Auger, Cristina

AU - Audoin, Bertrand

AU - Montalban, Xavier

AU - Tintore, Mar

AU - Mariotto, Sara

AU - Cobo-Calvo, Alvaro

AU - Marignier, Romain

PY - 2025/4/9

Y1 - 2025/4/9

N2 - In the Clinical/Scientific Note Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease by Villacieros-A lvarez et al., 1 the Study Funding should read as follows: This study has been funded by Instituto Carlos III through the projects PI20/00,800 granted to A.C.-C. and co-funded by the European Union. Additional funding is from Fondation pour laide à la recherche sur la sclerose en plaques (ARSEP) (ARSEP-1276). A. Cobo-Calvo is supported by Joan Rodes contract JR19/00,007 and Javier Villacieros-A lvarez by P-FIS grant FI21/00,282.The authors regret the omission.

AB - In the Clinical/Scientific Note Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease by Villacieros-A lvarez et al., 1 the Study Funding should read as follows: This study has been funded by Instituto Carlos III through the projects PI20/00,800 granted to A.C.-C. and co-funded by the European Union. Additional funding is from Fondation pour laide à la recherche sur la sclerose en plaques (ARSEP) (ARSEP-1276). A. Cobo-Calvo is supported by Joan Rodes contract JR19/00,007 and Javier Villacieros-A lvarez by P-FIS grant FI21/00,282.The authors regret the omission.

UR - https://www.scopus.com/pages/publications/105003323292

U2 - 10.1212/NXI.0000000000200401

DO - 10.1212/NXI.0000000000200401

M3 - Comment/debate

C2 - 40203209

AN - SCOPUS:105003323292

SN - 2332-7812

VL - 12

JO - Neurology: Neuroimmunology and NeuroInflammation

JF - Neurology: Neuroimmunology and NeuroInflammation

IS - 3

M1 - e200401

ER -

Villacieros-Álvarez J, Espejo C, Arrambide G, Dinoto A, Mulero P, Rubio-Flores L et al. Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362). Neurology: Neuroimmunology and NeuroInflammation. 2025 Apr 9;12(3):e200401. doi: 10.1212/NXI.0000000000200401

Correction: Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Neurol Neurimmunol Neuroinflamm. (2025) 12:2 (e200362) DOI: 10.1212/NXI.0000000000200362)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this